EMEA-000926-PIP01-10 - paediatric investigation plan

Dermatophagoides pteronyssinus

Dermatophagoides farinae

Key facts

• Active Substance:
  • Dermatophagoides pteronyssinus
  • Dermatophagoides farinae
• Therapeutic area:
  Pneumology-allergology
• Decision number:
  P/266/2010
• PIP number:
  EMEA-000926-PIP01-10
• Pharmaceutical form(s):
  Oromucosal solution
• Condition(s) / indication(s):
  Treatment of allergic rhinitis / rhino-conjunctivitis
• Route(s) of administration:
  Sublingual use
• Contact for public enquiries:

  LETI Pharma GmbH

  [e-mail]; Germany; Phone: [phone]; Fax: [phone]

• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  26/11/2010

Decision

P/266/2010: EMA decision of of 26 November 2010 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for mixture of Dermatophagoides pteronyssinus and Der...

AdoptedReference Number: EMA/716686/2010